FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2763239300> ?p ?o ?g. }

• W2763239300 endingPage "1618" @default.
• W2763239300 startingPage "1607" @default.
• W2763239300 abstract "Tumor necrosis factor-related apoptosis-induced ligand (TRAIL) is reported as a promising anti-cancer therapeutic agent. Nevertheless, a variety of cancer cells, including human malignant glioma cells, are resistant to TRAIL treatment, indicating that it is necessary to find effective strategies to overcome the TRAIL resistance. Linarin (LIN), a natural flavonoid compound in Flos Chrysanthemi Indici (FCI), has been exhibited to exert various pharmacological activities, including anti-cancer. Here in our study, we found that non-cytotoxic doses of LIN (5 μM) dramatically potentiated TRAIL (80 ng/ml)-induced cytotoxicity (52.36 ± 1.58%) and apoptosis (68.50 ± 1.23%) using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and flow cytometry assays, respectively, in human glioma cells of U87MG. Apoptosis was evidenced by enhanced cleavage of Caspase-8/-9/-3 and poly (ADP-ribose) polymerase (PARP), and reduced anti-apoptotic proteins, including B-cell leukemia/lymphoma 2 (Bcl-2), mantle cell lymphoma (Mcl)-1, and Survivin. Moreover, both intrinsic and extrinsic apoptosis pathways were included in apoptosis induced by LIN and TRAIL co-treatment, along with high release of Cyto-c into cytoplasm and enhancement of fas-associated protein with death domain (FADD), death-inducing signaling complex (DISC), death receptor 4 (DR) 4 and DR5, respectively. Reactive oxygen species (ROS) generation, up to 39.86 ± 2.32%, was also highly triggered by TRAIL and LIN combinational treatment, which was accompanied with high phosphorylation of c-Jun-N-terminal kinase (JNK). In vivo, TRAIL and LIN double treatment significantly reduced the tumor growth using xenograft tumor model through inducing apoptosis. We demonstrated that combining LIN with TRAIL treatments might be effective against TRAIL-resistant glioma cells through inducing apoptosis regulated by ROS generation." @default.
• W2763239300 created "2017-10-20" @default.
• W2763239300 creator A5039614239 @default.
• W2763239300 creator A5045067652 @default.
• W2763239300 creator A5046305086 @default.
• W2763239300 creator A5063623698 @default.
• W2763239300 creator A5067001113 @default.
• W2763239300 creator A5074617332 @default.
• W2763239300 date "2017-11-01" @default.
• W2763239300 modified "2023-10-18" @default.
• W2763239300 title "Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice" @default.
• W2763239300 cites W1467002712 @default.
• W2763239300 cites W1521631645 @default.
• W2763239300 cites W1526360775 @default.
• W2763239300 cites W1899594293 @default.
• W2763239300 cites W1965694039 @default.
• W2763239300 cites W1966743152 @default.
• W2763239300 cites W1978660258 @default.
• W2763239300 cites W1979376504 @default.
• W2763239300 cites W1980019367 @default.
• W2763239300 cites W1985087138 @default.
• W2763239300 cites W1990282735 @default.
• W2763239300 cites W1990780864 @default.
• W2763239300 cites W2000223779 @default.
• W2763239300 cites W2009906545 @default.
• W2763239300 cites W2010496850 @default.
• W2763239300 cites W2015523279 @default.
• W2763239300 cites W2017369330 @default.
• W2763239300 cites W2018535512 @default.
• W2763239300 cites W2019843278 @default.
• W2763239300 cites W2022050076 @default.
• W2763239300 cites W2022853846 @default.
• W2763239300 cites W2023848967 @default.
• W2763239300 cites W2027987606 @default.
• W2763239300 cites W2028107828 @default.
• W2763239300 cites W2034249182 @default.
• W2763239300 cites W2039774023 @default.
• W2763239300 cites W2043347023 @default.
• W2763239300 cites W2048389080 @default.
• W2763239300 cites W2048986808 @default.
• W2763239300 cites W2050099527 @default.
• W2763239300 cites W2056493735 @default.
• W2763239300 cites W2057929536 @default.
• W2763239300 cites W2075290185 @default.
• W2763239300 cites W2092508425 @default.
• W2763239300 cites W2097804537 @default.
• W2763239300 cites W2100324029 @default.
• W2763239300 cites W2102261319 @default.
• W2763239300 cites W2104264382 @default.
• W2763239300 cites W2107377459 @default.
• W2763239300 cites W2111573377 @default.
• W2763239300 cites W2114871525 @default.
• W2763239300 cites W2119316865 @default.
• W2763239300 cites W2122202911 @default.
• W2763239300 cites W2126917392 @default.
• W2763239300 cites W2135830946 @default.
• W2763239300 cites W2147407111 @default.
• W2763239300 cites W2150931400 @default.
• W2763239300 cites W2154846683 @default.
• W2763239300 cites W2219362984 @default.
• W2763239300 cites W2285241965 @default.
• W2763239300 cites W2303836374 @default.
• W2763239300 cites W2317538561 @default.
• W2763239300 cites W2343108720 @default.
• W2763239300 cites W2398317311 @default.
• W2763239300 cites W2498052270 @default.
• W2763239300 cites W2514636307 @default.
• W2763239300 cites W2547463738 @default.
• W2763239300 cites W2582131052 @default.
• W2763239300 cites W2588177032 @default.
• W2763239300 cites W2607357550 @default.
• W2763239300 doi "https://doi.org/10.1016/j.biopha.2017.08.021" @default.
• W2763239300 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28950661" @default.
• W2763239300 hasPublicationYear "2017" @default.
• W2763239300 type Work @default.
• W2763239300 sameAs 2763239300 @default.
• W2763239300 citedByCount "15" @default.
• W2763239300 countsByYear W27632393002018 @default.
• W2763239300 countsByYear W27632393002019 @default.
• W2763239300 countsByYear W27632393002020 @default.
• W2763239300 countsByYear W27632393002021 @default.
• W2763239300 countsByYear W27632393002022 @default.
• W2763239300 countsByYear W27632393002023 @default.
• W2763239300 crossrefType "journal-article" @default.
• W2763239300 hasAuthorship W2763239300A5039614239 @default.
• W2763239300 hasAuthorship W2763239300A5045067652 @default.
• W2763239300 hasAuthorship W2763239300A5046305086 @default.
• W2763239300 hasAuthorship W2763239300A5063623698 @default.
• W2763239300 hasAuthorship W2763239300A5067001113 @default.
• W2763239300 hasAuthorship W2763239300A5074617332 @default.
• W2763239300 hasConcept C109316439 @default.
• W2763239300 hasConcept C121608353 @default.
• W2763239300 hasConcept C153911025 @default.
• W2763239300 hasConcept C154317977 @default.
• W2763239300 hasConcept C17991360 @default.
• W2763239300 hasConcept C185592680 @default.
• W2763239300 hasConcept C190283241 @default.
• W2763239300 hasConcept C202751555 @default.

• next